MAY 2023 Research Alert

This month we added three new studies to the Best Practice Database, the research repository for Best Practices, LLC. This month's new studies explore two topical areas: propelling an ophthalmic blockbuster and constructing Medical’s road map for social media success in Rare Disease segment. The first case study is about how Tepezza implemented exceptional launch and market entry strategies to become an ophthalmic blockbuster. The last two studies investigate current trends and success factors in harnessing social media for effectively educating the Rare Disease market.

The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.

	Download: Case Study: How Horizon Therapeutics Created an Ophthalmic Blockbuster in a Rare Disease Autoimmune Area for Thyroid Eye Disease (5760) This case study reviews Tepezza’s trajectory to achieving blockbuster status in a rare disease autoimmune area for thyroid eye disease through exceptional market entry strategies and execution.
	Download: Medical’s Road Map for Social Media Success in Rare Disease Segment: Structure and Activities (5761) This benchmark study examines the optimal structure for Medical Affairs groups to engage in social media initiatives and highlights key social media activities for effectively educating the Rare Disease market.
	Download: Medical’s Road Map for Social Media Success in Rare Disease Segment: Omnichannel Integration and Message Characteristics (5762) Best Practices, LLC undertook this research to establish benchmarks around social media omnichannel integration, social media message characteristics, and performance measurement.